About ARCA
Our Focus
ARCA was founded on the belief that a precision medicine approach to drug development, tailoring medical treatment to the individual genetic characteristics of patients, can enable more effective therapies, improve patient outcomes and reduce healthcare costs.
Gencaro™ (bucindolol hydrochloride) is an investigational compound with potential as a treatment for atrial fibrillation in patients with heart failure. ARCA has identified genetic variations in cardiac receptors that we believe may predict individual patient response to Gencaro™, giving Gencaro™ the potential to be the first genetically-targeted cardiovascular therapeutic.
About ARCA
Our Focus
ARCA was founded on the belief that a precision medicine approach to drug development, tailoring medical treatment to the individual genetic characteristics of patients, can enable more effective therapies, improve patient outcomes and reduce healthcare costs.
Gencaro™ (bucindolol hydrochloride) is an investigational compound with potential as a treatment for atrial fibrillation in patients with heart failure. ARCA has identified genetic variations in cardiac receptors that we believe may predict individual patient response to Gencaro™, giving Gencaro™ the potential to be the first genetically-targeted cardiovascular therapeutic.
Management
Michael R. Bristow, M.D., Ph.D.
President & Chief Executive Officer
Dr. Bristow was one of the founders of ARCA in September 2004, and has served as a Director since that...[+more]
Thomas A. Keuer
Chief Operating Officer
Mr. Keuer has served as the Company’s Chief Operating Officer since December 2014. Mr. Keuer served as the Company’s Executive Vice...[+more]
Jeff Dekker
Chief Financial Officer
Mr. Dekker has served as the Company’s Chief Financial Officer since May 2021. Prior to joining the Company, Mr. Dekker...[+more]
Board of Directors
Robert E. Conway
Chairman
Mr. Conway was appointed to the Board of Directors in September 2013, and has served as the Chairman of our...[+more]
Michael R. Bristow, M.D., Ph.D.
Chief Executive Officer
Dr. Bristow was one of the founders of ARCA in September 2004, and has served as a Director since that...[+more]
Linda Grais, M.D.
Director
Dr. Grais has served as a member of the Board of Directors since May 2007. Dr. Grais has been a director...[+more]
Anders Hove M.D.
Director
Dr. Hove has served as a member of the Board of Directors since February 2017. Dr. Hove is the manager...[+more]
Dan Mitchell
Director
Mr. Mitchell was appointed to the Board of Directors in February 2014. He founded, and was a manager of Sequel...[+more]
Jacob Ma-Weaver
Director
Mr. Ma-Weaver was appointed to the Board of Directors in June 2022. Mr. Ma-Weaver is the Managing Member of Cable...[+more]
Raymond L. Woosley, M.D., Ph.D.
Director
Dr. Woosley was appointed to the Board of Directors in July 2013. Since 2012, Dr. Woosley has been the Director...[+more]
James Flynn
Director
Mr. Flynn is currently a Managing Member and Portfolio Manager of Nerium Capital LLC, an investment adviser he founded in...[+more]